{
  "ticker": "GCM",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963649",
  "id": "02963649",
  "pages": 39,
  "price_sensitive": false,
  "date": "20250630",
  "time": "1229",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250630/pdf/06l87s508lbnb7.pdf",
  "summary": "### **Material Information Summary**  \n\n#### **Capital Raising & Shareholder Approval Details**  \n- **Placement Structure**:  \n  - **Tranche 1 Placement Shares**: Already issued (10 June 2025) under Listing Rules 7.1/7.1A:  \n    - **294.5m shares** (Listing Rule 7.1) + **193.0m shares** (Listing Rule 7.1A).  \n    - **Issue price**: **A$0.012/share**.  \n  - **Tranche 2 Placement Shares**: **95.8m shares** (A$0.012/share) subject to shareholder approval (Resolution 2).  \n  - **Placement Options**: **291.7m options** (1:2 ratio, strike A$0.022, 2-year expiry) subject to approval (Resolution 3).  \n  - **Lead Manager Options**: **20.0m options** (same terms as Placement Options) to Joint Lead Managers (Resolution 4).  \n\n- **Use of Funds**:  \n  - Commercialization of VHD Technology, McIntosh Graphite Project development, and working capital.  \n\n#### **Director-Related Issuances**  \n- **Performance Rights Cancellation (Resolution 5)**:  \n  - Cancel **20.0m unvested performance rights** issued to MD Clinton Booth.  \n- **Director Shares (Resolution 6)**:  \n  - Issue **10.0m shares** to Booth at **A$0.0000001/share** as part of remuneration restructuring.  \n- **New Performance Rights (Resolutions 7a\u20137c)**:  \n  - **Total 147.5m rights** issued to directors (Booth: 117.5m; Thomas/Zielinski: 15m each) tied to operational/share price milestones.  \n\n#### **Key Dates**  \n- **General Meeting**: **30 July 2025** (11:00 AM AWST).  \n- **Proxy Deadline**: **28 July 2025** (11:00 AM AWST).  \n- **Tranche 2/Option Issuance**: Within **3 months** post-meeting if approved.  \n\n#### **Voting Exclusions**  \n- Restrictions apply to votes by placement participants, directors, and associates on related resolutions.  \n\n#### **Valuation Impact**  \n- **Dilution**: Up to **5.67%** post-issuance (assuming full conversion of performance rights).  \n- **Performance Rights Valuation**: **Total A$1.76m** (externally assessed).  \n\n---  \n**Note**: Excludes procedural/boilerplate details. Focused on material capital, governance, and trading implications.",
  "usage": {
    "prompt_tokens": 24608,
    "completion_tokens": 571,
    "total_tokens": 25179,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-30T03:18:34.439853"
}